TNKase (T-N-Kase, tenecteplase), a new "third generation" thrombolytic for heart attacks
December 2001
Hoffmann-La Roche is now introducing TNKase (T-N-Kase, tenecteplase), a new "third generation" thrombolytic for heart attacks.
TNKase and the other "third generation" med Retavase (reteplase) are faster and easier to give than older thrombolytics.
TNKase is made by substituting three amino acids of the thrombolytic Activase (alteplase, tPA).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive